{"id":3862,"date":"2018-08-01T06:10:19","date_gmt":"2018-08-01T06:10:19","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/"},"modified":"2018-08-01T06:10:19","modified_gmt":"2018-08-01T06:10:19","slug":"nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/","title":{"rendered":"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag."},"content":{"rendered":"
<\/strong><\/div>\n

Nanexa har tecknat ett samarbetsavtal med f\u00f6retaget ViroVet i Belgien f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\u00a0tillsammans med en av deras nya l\u00e4kemedelssubstanser f\u00f6r behandling av en virusrelaterad sjukdom i boskap.<\/strong><\/span><\/p>\n

ViroVet \u00e4r ett bolag verksamt inom utveckling av nya effektiva behandlingar och vacciner f\u00f6r olika virussjukdomar i boskap. Samarbetet som nu startar syftar till att utv\u00e4rdera Nanexas drug deliveryplattform PharmaShell\u00ae\u00a0f\u00f6r att f\u00f6rb\u00e4ttra en av ViroVets nya substanser f\u00f6r behandling av en luftv\u00e4gssjukdom hos n\u00f6tkreatur orsakad av virus. Deras m\u00e5ls\u00e4ttning \u00e4r att skapa en effektiv och l\u00e5ngverkande l\u00e4kemedelsprodukt som ocks\u00e5 minimerar djurhantering.<\/span><\/p>\n

Den globala marknaden f\u00f6r animal helath v\u00e4rderas till 42.2 miljarder USD med en \u00e5rlig tillv\u00e4xt p\u00e5 5,5%. Denna marknad inkluderar b\u00e5de boskap och s\u00e4llskapsdjur d\u00e4r merparten (ca 2\/3) \u00e4r relaterat till boskapsdjur.*
Avtalet som nu tecknats \u00e4r ett ett\u00e5rigt samarbetsavtal d\u00e4r Nanexa bel\u00e4gger ViroVets l\u00e4kemedelspartiklar och ViroVet utv\u00e4rderar i dessa formuleringar i relevant djurmodell. Vardera part b\u00e4r sina kostnader i detta initiala skede.<\/span><\/p>\n

Nanexas VD David Westberg kommenterar:<\/span><\/p>\n

Jag \u00e4r givetvis mycket n\u00f6jd med detta avtal som ger oss m\u00f6jligheten att samarbeta i en expansiv marknad med ett mycket intressant f\u00f6retag. Det kan \u00f6ppna ytterligare en intressant marknad, vid sidan av utlicensiering av PharmaShell\u00ae\u00a0teknologin till l\u00e4kemedelsf\u00f6retag och utvecklingen av v\u00e5rt eget produktprojekt.<\/span><\/p>\n

En f\u00f6rdel med utveckling av l\u00e4kemedel f\u00f6r djur \u00e4r att utvecklingstiden \u00e4r kortare \u00e4n f\u00f6r l\u00e4kemedel f\u00f6r humant bruk, vilket g\u00f6r att f\u00f6rs\u00e4ljning av produkt till marknad kan ske tidigare.<\/span><\/p>\n

*Grand View Research, June 2018.<\/span><\/p>\n

F\u00f6r mer information kontakta:
David Westberg \u2013 VD, Nanexa AB (publ)\u00a0Telefon: 0709 -42 83 03
E-post: david.westberg@nanexa.se www.nanexa.se<\/span><\/p>\n

Om Nanexa AB (publ)<\/span><\/p>\n

Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Karolinska Institutet.<\/span><\/p>\n

\n

Bifogade filer<\/strong><\/p>\n\n

<\/a><\/p>\n<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa har tecknat ett samarbetsavtal med f\u00f6retaget ViroVet i Belgien f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\u00a0tillsammans med en av deras nya l\u00e4kemedelssubstanser f\u00f6r behandling av en virusrelaterad sjukdom i boskap.<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3862","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa har tecknat ett samarbetsavtal med f\u00f6retaget ViroVet i Belgien f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\u00a0tillsammans med en av deras nya l\u00e4kemedelssubstanser f\u00f6r behandling av en virusrelaterad sjukdom i boskap.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\\\/\",\"name\":\"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2018-08-01T06:10:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB","og_description":"Nanexa har tecknat ett samarbetsavtal med f\u00f6retaget ViroVet i Belgien f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\u00a0tillsammans med en av deras nya l\u00e4kemedelssubstanser f\u00f6r behandling av en virusrelaterad sjukdom i boskap.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/","name":"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag. - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2018-08-01T06:10:19+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-samarbetsavtal-med-europeiskt-animal-health-foretag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa tecknar samarbetsavtal med Europeiskt animal health f\u00f6retag."}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}